Trial intelligence / Profile preview

Prospective randomized multicenter trial to compare Taurolock catheter lock solution

2019-001340-22Phase 4Completed

Sponsor
Landesklinikum St. Pölten
Start
Jan 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of taurolidine in kidney failure (2 arms), sponsored by Landesklinikum St. Pölten. Primary endpoint: Total number of catheter dysfunctions. Started Jan 2020; status: completed.

02

Drugs

taurolidine
03

Conditions

kidney failure

Beyond the preview

Go deeper on 2019-001340-22.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2019-001340-22.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call